HIDA scan (hepatobiliary iminodiacetic acid scan, also called cholescintigraphy) uses a radioactive tracer to evaluate the function of liver, gallbladder, and bile ducts. Procedure – patient lies on imaging table; radioactive tracer (technetium-99m labeled with HIDA compound) injected into vein; tracer absorbed by liver, secreted into bile; gamma camera captures images as tracer moves through liver, into gallbladder, and into small intestine; standard test 60-90 minutes; possible CCK injection – cholecystokinin medication injected to stimulate gallbladder contraction, measures ejection fraction (normal greater than 38%), takes 30 additional minutes. Total study 60-120 minutes. Information provided – bile duct patency, gallbladder visualization, gallbladder ejection fraction (functional capacity), leak detection (post-surgery), acute cholecystitis. Indications – when ultrasound normal but symptoms suggest gallbladder disease (functional gallbladder disease); acute cholecystitis evaluation; biliary leak after surgery; pediatric biliary atresia; sphincter of Oddi dysfunction. For diabetes patients – useful diagnostic tool for vague upper abdominal symptoms. Multiple risk factors for gallbladder issues in diabetes. Adults with diabetes have 2-3x higher gallstone risk than general population. Possible mechanisms – obesity (shared risk factor; major driver); hyperinsulinemia (promotes cholesterol secretion into bile; increases gallstone formation); diabetic gallbladder dysmotility (delayed emptying – autonomic neuropathy); hypertriglyceridemia (common in diabetes; affects bile composition); rapid weight loss (significant trigger; particularly with bariatric surgery or GLP-1 agonists); GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide – FDA labeling notes increased gallbladder disease risk – about 0.5-1% absolute risk increase per year). Common presentation in diabetes – asymptomatic gallstones common (50-70% of diabetic patients with gallstones have no symptoms); when symptomatic – right upper quadrant pain, especially after fatty meals; nausea, vomiting; pain radiating to back/shoulder. Gallbladder ejection fraction (GBEF) – percentage of bile expelled when gallbladder contracts; measured after CCK injection during HIDA scan. Normal greater than 38%; abnormal less than 38% suggests functional gallbladder disease.
HIDA Scan Indications
| Indication | What it Evaluates |
|---|---|
| Suspected acute cholecystitis | Gallbladder visualization (non-visualization = positive) |
| Functional gallbladder disease | Ejection fraction; biliary dyskinesia |
| Bile leak after surgery | Tracer leak outside biliary system |
| Sphincter of Oddi dysfunction | Delayed transit through ampulla |
| Biliary atresia (pediatric) | Patent bile drainage |
| Post-cholecystectomy syndrome | Sphincter dysfunction |
HIDA Scan Results
| Finding | Interpretation |
|---|---|
| Normal tracer flow, GBEF over 38% | Normal |
| Non-visualization of gallbladder at 1 hour | Acute cholecystitis likely |
| Delayed visualization (1-4 hours) | Chronic cholecystitis possible |
| GBEF less than 38% | Functional gallbladder disease (biliary dyskinesia) |
| Bile leak | Post-surgical complication |
| Reflux into stomach | Sphincter of Oddi dysfunction or other |
Diabetes Gallbladder Risk Factors
- Obesity – shared risk factor; major driver.
- Hyperinsulinemia promotes cholesterol secretion into bile.
- Diabetic gallbladder dysmotility (autonomic neuropathy).
- Hypertriglyceridemia affects bile composition.
- Rapid weight loss (especially bariatric surgery, GLP-1 agonists).
- GLP-1 receptor agonists – FDA labeling notes increased risk.
- Female sex (women higher gallstone risk anyway).
- Age (gallstones more common with age).
- Family history of gallstones.
- Native American ethnicity (higher gallstone risk).
Gallbladder Symptoms to Recognize
- Right upper quadrant pain, especially after fatty meals.
- Pain may radiate to right shoulder or back.
- Nausea and vomiting.
- Episodic pain (biliary colic).
- Fever (suggests infection – cholecystitis).
- Jaundice (yellow skin/eyes – bile duct obstruction).
- Clay-colored stools (bile not reaching intestine).
- Dark urine (bile in urine).
- Indigestion, bloating.
- Belching.
Diagnostic Workup
- Ultrasound first – shows gallstones; cheap, non-invasive.
- HIDA scan if ultrasound normal but symptoms persist.
- CT abdomen – alternative imaging.
- MRCP – magnetic resonance imaging of bile ducts.
- ERCP – therapeutic and diagnostic for bile duct stones.
- Liver function tests – check for elevated alkaline phosphatase, bilirubin.
- Lipase/amylase – rule out pancreatitis.
- Endoscopic ultrasound – for some indications.
Treatment Options
- Asymptomatic gallstones – usually no treatment in diabetes.
- Symptomatic gallstones – cholecystectomy (laparoscopic preferred).
- Acute cholecystitis – admission, IV antibiotics, often cholecystectomy.
- Functional gallbladder disease – cholecystectomy if confirmed by HIDA.
- Bile duct stones – ERCP for stone removal.
- Dietary modification – low-fat diet, weight management.
- Ursodeoxycholic acid (Actigall) – dissolves cholesterol stones; long process.
- Address GLP-1 agonist if iatrogenic gallbladder disease.
- Cholecystectomy outcomes in diabetes – slightly higher complication rate.
The Bottom Line
HIDA scan (hepatobiliary iminodiacetic acid scan, also called cholescintigraphy) uses a radioactive tracer to evaluate the function of liver, gallbladder, and bile ducts. Procedure – radioactive tracer injected into vein; tracer absorbed by liver, secreted into bile; gamma camera captures images as tracer moves through liver, into gallbladder, and into small intestine; standard test 60-90 minutes; possible CCK injection to stimulate gallbladder contraction (measures ejection fraction). Total study 60-120 minutes. Information provided – bile duct patency, gallbladder visualization, gallbladder ejection fraction, leak detection, acute cholecystitis. Indications – when ultrasound normal but symptoms suggest gallbladder disease (functional gallbladder disease); acute cholecystitis evaluation; biliary leak after surgery; sphincter of Oddi dysfunction. Multiple risk factors for gallbladder issues in diabetes. Adults with diabetes have 2-3x higher gallstone risk than general population. Possible mechanisms – obesity (shared risk factor; major driver); hyperinsulinemia (promotes cholesterol secretion into bile); diabetic gallbladder dysmotility (delayed emptying – autonomic neuropathy); hypertriglyceridemia; rapid weight loss (significant trigger; particularly with bariatric surgery or GLP-1 agonists); GLP-1 receptor agonists (FDA labeling notes increased gallbladder disease risk – about 0.5-1% absolute risk increase per year). Common presentation in diabetes – asymptomatic gallstones common (50-70% of diabetic patients with gallstones have no symptoms); when symptomatic – right upper quadrant pain, especially after fatty meals; nausea, vomiting; pain radiating to back/shoulder. Gallbladder ejection fraction (GBEF) – percentage of bile expelled when gallbladder contracts; measured after CCK injection during HIDA scan. Normal greater than 38%; abnormal less than 38% suggests functional gallbladder disease (biliary dyskinesia). Functional gallbladder disease – gallbladder symptoms (right upper quadrant pain, nausea after meals) without gallstones; reduced ejection fraction on HIDA; some patients improve with cholecystectomy. Treatment – asymptomatic gallstones usually no treatment in diabetes; symptomatic gallstones – cholecystectomy (laparoscopic preferred); acute cholecystitis – admission, IV antibiotics, often cholecystectomy; functional gallbladder disease – cholecystectomy if confirmed by HIDA; dietary modification (low-fat diet, weight management); address GLP-1 agonist if iatrogenic gallbladder disease. For adults with type 2 diabetes – elevated gallbladder disease risk; HIDA useful when ultrasound normal but symptoms persist; GLP-1 agonist users should be aware of FDA label warning; report new gallbladder symptoms promptly. See our broader prediabetes detection guide.
